The Molecular Diagnostics Market is predicted to reach US$ 21.1 billion by 2030 from US$ 21.1 billion in 2021, and to grow at a CAGR of ~5.10% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Product & Services [Systems & Instruments, Assay Reagents & Kits, and Software & Service], Technology [Polymerase Chain Reaction (PCR), DNA Sequencing & Next-Generation Sequencing (NGS), In Situ Hybridization, and Microarrays], Application [Infectious disease, Oncology, Pharmacogenomics, Genetic Testing], End User [Hospitals, Academic Institutes & Research Centers and Clinical & Pathology Labs]
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
F. Hoffmann-La Roche Ltd., bioMérieux SA, Beckman Coulter Inc., Becton Dickinson & Company, Siemens Healthcare Private Limited, Grifols SA, Abbott Laboratories Inc, Hologic Inc., Danaher Corporation and QIAGEN NV among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Molecular Diagnostics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Molecular Diagnostics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Molecular Diagnostics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Molecular Diagnostics - ANALYSIS & FORECAST, BY REGION
North America Molecular Diagnostics
1. North America Molecular Diagnostics , by Country
1. US
2. Canada
1. North America Molecular Diagnostics , by Product
2. North America Molecular Diagnostics , by Type
3. North America Molecular Diagnostics , by Gender
4. North America Molecular Diagnostics , by Sales Channel
3. Europe Molecular Diagnostics
1. Europe Molecular Diagnostics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Molecular Diagnostics , by Product
3. Europe Molecular Diagnostics , by Type
4. Europe Molecular Diagnostics , by Gender
5. Europe Molecular Diagnostics , by Sales Channel
4. Asia Pacific Molecular Diagnostics
1. Asia Pacific Molecular Diagnostics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Molecular Diagnostics , by product
3. Asia Pacific Molecular Diagnostics , by Type
4. Asia Pacific Molecular Diagnostics , by Gender
5. Asia Pacific Molecular Diagnostics , by Sales Channel
5. Rest of the World Molecular Diagnostics
1. Rest of the World Molecular Diagnostics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Molecular Diagnostics , by Product
3. Rest of the World Molecular Diagnostics , by Type
4. Rest of the World Molecular Diagnostics , by Gender
5. Rest of the World Molecular Diagnostics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 40